Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic LeukemiaPatrick A. Brown, Mignon L. Loh, James A. Whitlock et al.|JAMA|2021Cited by 358
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03)Todd M. Cooper, Patrick A. Brown, Edward Allan R. Sison et al.|Pediatric Blood & Cancer|2017Cited by 73
Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid TumorsR. Bagatell, Lia Gore, Cynthia E. Herzog et al.|Clinical Cancer Research|2010Cited by 48
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhoodKenneth J. Cohen, Lia Gore, Iris C. Gibbs et al.|Neuro-Oncology|2013Cited by 46
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AMLLia Gore, Bodour Salhia, Timothy J. Triche et al.|Clinical Epigenetics|2017Cited by 45